Published in J Clin Oncol on November 29, 2010
Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol (2016) 1.66
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol (2011) 1.45
Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist (2011) 1.42
Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain. PLoS One (2015) 1.40
Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol (2013) 1.32
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol (2013) 1.18
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat (2011) 1.15
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res Treat (2011) 1.09
Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies. BMJ (2016) 1.07
Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res (2012) 1.04
Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control (2012) 1.04
Risk of cancer in diabetes: the effect of metformin. ISRN Endocrinol (2013) 1.04
The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist (2012) 1.03
Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Res (2012) 1.01
Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol (2010) 1.01
Glucose promotes breast cancer aggression and reduces metformin efficacy. Cell Cycle (2013) 0.99
Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers. Ann Transl Med (2014) 0.97
Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis--a Danish nationwide matched cohort study. PLoS One (2013) 0.94
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer. Cancers (Basel) (2015) 0.93
Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp Diabetes Res (2012) 0.93
Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol (2014) 0.92
Highly specific role of the insulin receptor in breast cancer progression. Endocr Relat Cancer (2015) 0.90
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression. Oncologist (2016) 0.90
Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia. J Am Heart Assoc (2012) 0.88
Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Res Treat (2014) 0.88
Metabolic syndrome and breast cancer: is there a link? Breast Care (Basel) (2014) 0.88
Recent advances in the use of metformin: can treating diabetes prevent breast cancer? Biomed Res Int (2015) 0.87
Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One (2014) 0.85
Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Res (2015) 0.85
Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat (2014) 0.84
Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress. Oxid Med Cell Longev (2015) 0.84
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocr Relat Cancer (2013) 0.84
Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with Diabetes. J Diabetes Res (2015) 0.83
Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Oncogene (2011) 0.83
Lifestyle interventions for cardiovascular risk reduction in women with breast cancer. Curr Cardiol Rev (2011) 0.82
Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract (2014) 0.82
High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLoS One (2014) 0.81
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. BMC Cancer (2012) 0.81
Prolonged Nightly Fasting and Breast Cancer Prognosis. JAMA Oncol (2016) 0.80
Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China. Onco Targets Ther (2014) 0.80
Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation. Neuro Oncol (2015) 0.80
Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome. Eur J Cancer (2016) 0.80
Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus. Mol Clin Oncol (2015) 0.79
Associations between Diabetes and Quality of Life among Breast Cancer Survivors. PLoS One (2016) 0.79
Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links. Biomed Rep (2014) 0.79
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev (2013) 0.78
The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors. Sci Signal (2015) 0.77
Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiol Drug Saf (2014) 0.77
Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis. Asia Pac J Oncol Nurs (2017) 0.77
Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study. Tumour Biol (2015) 0.76
Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist. FASEB J (2015) 0.76
Diabetes and breast cancer mortality in Black women. Cancer Causes Control (2016) 0.75
Relationship between level of HbA1C and breast cancer. BBA Clin (2016) 0.75
Time to follow-up of an abnormal mammogram in women with diabetes: a population-based study. Cancer Med (2016) 0.75
Acute Hyperglycemia Associated with Anti-Cancer Medication. Endocrinol Metab (Seoul) (2017) 0.75
Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study. Cancer Causes Control (2016) 0.75
Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways. Diabetes Metab Res Rev (2016) 0.75
Pre-Existing Diabetes in Early Stage Breast Cancer Patients is Associated with Lack of Improvement in Quality of Life 2 Years After Diagnosis. Int J Behav Med (2016) 0.75
Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells. PLoS One (2016) 0.75
Diabetes and Breast Cancer Subtypes. PLoS One (2017) 0.75
The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells. Oncotarget (2015) 0.75
Does insulin resistance influence breast cancer outcomes? Nat Rev Endocrinol (2011) 0.75
Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes Control (2015) 0.75
Role of breast cancer inhibitors on diabetes mellitus- an in silico approach. J Diabetes Metab Disord (2015) 0.75
Correlations Between Abnormal Glucose Metabolism and Bone Mineral Density or Bone Metabolism. Med Sci Monit (2016) 0.75
Heparanase augments insulin receptor signaling in breast carcinoma. Oncotarget (2016) 0.75
Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer Metab (2016) 0.75
Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010-2030. Cancer Sci (2016) 0.75
Recent relocation and decreased survival following a cancer diagnosis. Prev Med (2016) 0.75
Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life. Asia Pac J Oncol Nurs (2017) 0.75
Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer. J Cancer Surviv (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 10.18
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
Metformin in breast cancer: time for action. J Clin Oncol (2009) 3.81
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle (2009) 3.34
Comorbidity and survival disparities among black and white patients with breast cancer. JAMA (2005) 3.27
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst (2008) 2.94
Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev (2009) 2.66
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer (2007) 2.64
Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer (2008) 2.53
Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab (2006) 2.52
Diabetes mellitus and breast cancer. Lancet Oncol (2005) 2.34
Expanding priorities--confronting chronic disease in countries with low income. N Engl J Med (2007) 2.34
Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol (2009) 1.98
The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat (2007) 1.98
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia (2010) 1.76
Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat (2005) 1.74
A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care (1999) 1.57
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Sulphonylureas and cancer: a case-control study. Acta Diabetol (2008) 1.56
Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care (2005) 1.55
Screening mammogram utilization in women with diabetes. Diabetes Care (2001) 1.33
If mammalian target of metformin indirectly is mammalian target of rapamycin, then the insulin-like growth factor-1 receptor axis will audit the efficacy of metformin in cancer clinical trials. J Clin Oncol (2009) 1.01
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 14.41
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol (2006) 11.26
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
Readability standards for informed-consent forms as compared with actual readability. N Engl J Med (2003) 7.58
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59
Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med (2008) 6.54
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol (2014) 5.61
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. JAMA Intern Med (2013) 4.49
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA (2003) 4.33
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2008) 4.29
Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA (2006) 4.27
Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med (2010) 4.24
Nonalcoholic fatty liver disease. Gastroenterology (2002) 4.15
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol (2010) 3.87
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 3.69
Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med (2008) 3.54
Neighborhood characteristics and availability of healthy foods in Baltimore. Am J Prev Med (2008) 3.46
Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med (2013) 3.44
Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care (2011) 3.36
Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med (2008) 3.32
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05
Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96
Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2007) 2.92
The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med (2009) 2.84
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med (2010) 2.72
Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med (2009) 2.70
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med (2005) 2.67
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract (2010) 2.59
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50
Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care (2009) 2.49
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. J Clin Oncol (2012) 2.45
Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care (2003) 2.38
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med (2009) 2.30
A systematic review of interactive computer-assisted technology in diabetes care. Interactive information technology in diabetes care. J Gen Intern Med (2005) 2.28
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol (2009) 2.26
Impact of attending physician workload on patient care: a survey of hospitalists. JAMA Intern Med (2013) 2.25
The burden and treatment of diabetes in elderly individuals in the u.s. Diabetes Care (2006) 2.19
Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med (2011) 2.19
HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw (2006) 2.15
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res (2011) 2.12
Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med (2003) 2.12
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clin Cancer Res (2012) 2.07
Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care (2004) 2.03
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol (2007) 2.01
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care (2010) 1.92
Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol (2006) 1.91
Hepatitis C virus infection and incident type 2 diabetes. Hepatology (2003) 1.89
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw (2006) 1.88
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. J Clin Oncol (2012) 1.85
Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin (2007) 1.84
Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation (2004) 1.81
Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet (2009) 1.81
Performance of A1C for the classification and prediction of diabetes. Diabetes Care (2010) 1.80
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2011) 1.78
Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol (2013) 1.77
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med (2015) 1.76
Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol (2003) 1.75
Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.75
The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw (2009) 1.73
Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care (2005) 1.72
Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer. J Clin Oncol (2011) 1.69
Thirty-six-item short-form outcomes following a randomized controlled trial in type 2 diabetes. Diabetes Care (2005) 1.64
Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity (Silver Spring) (2010) 1.64
Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care (2002) 1.64
Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Dis Manag (2004) 1.63